3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Gastrointestinal
1
Conditions
Colorectal Neoplasms
5
Lung Neoplasms
3
Breast Neoplasms
3
Pancreatic Neoplasms
2
Multiple Myeloma
2
Gastrointestinal Neoplasms
2
Uterine Cervical Neoplasms
1
Support of the Family as a Caregiving System
1
Stomach Neoplasms
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pain
1
Otorhinolaryngologic Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Malignant Female Reproductive System Neoplasm
1
Lymphoma, Follicular
1
Lymphoma
1
Localized Head and Neck Carcinoma
1
Lewy Body Disease
1
Interventions
Cisplatin
253
Radiotherapy
176
Cetuximab
145
pembrolizumab
120
Docetaxel
97
Fluorouracil
92
Carboplatin
80
Paclitaxel
77
Radiotherapy, Intensity-Modulated
69
Nivolumab
37
Radiation
30
Drug Therapy
30
Erlotinib Hydrochloride
26
Gemcitabine
25
Cyclophosphamide
22
Gefitinib
21
Surveys and Questionnaires
20
Standard of Care
20
Surgical Procedures, Operative
19
Pemetrexed
19
durvalumab
18
Magnetic Resonance Spectroscopy
17
Capecitabine
17
Radiosurgery
16
Celecoxib
16
atezolizumab
15
Filgrastim
15
Amifostine
15
130-nm albumin-bound paclitaxel
15
fludarabine
14
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Head and Neck Neoplasms
×
Referral and Consultation
×
Clear all
NCT03102229
2026-04-13
RAMPART
Montefiore Medical Center
Phase NA
Completed
40 enrolled